Nasdaq
$6.40▼ 0.16%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $558.6MShares out 87.3M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
11- 10.16After-hours26.10.17 06:58SCHEDULE 13D/AOwnership#●●●#●●●
Olema Pharmaceuticals, Inc.
BIOTECHNOLOGY VALUE FUND L.P. has filed a SCHEDULE 13D/A amendment regarding its beneficial ownership in Olema Pharmaceuticals, Inc. This filing serves to formally update the status of the reporting person's equity holdings in the company.…more
$6.40-0.16%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.15After-hours26.10.16 06:008-KKey event
Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals announced that Dr. Gorjan Hrustanovic resigned from the Board of Directors and its committees, effective October 14, 2026. Subsequently, Dr. Prakash Raman was appointed to the Compensation Committee and the Science and Technology Committee, effective October 15, 2026.…more
$6.40-0.16%vs prev closeView filingShare - 9.2After-hours26.09.03 05:304Ownership
Olema Pharmaceuticals, Inc.
Executive Jason O'Byrne of Olema Pharmaceuticals reported changes in beneficial ownership of company securities effective September 1, 2026. This filing is a standard Form 4 disclosure regarding insider holdings.…more
$6.40-0.16%vs prev closeView filingShare
10 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.2After-hours26.10.03 05:30#●●●
Olema Oncology Grants Stock Options to New Employees
Olema Oncology has granted stock options for a total of 235,950 shares to six new employees as an employment inducement. This award is a standard compensation practice for talent acquisition and does not impact the company's immediate financial performance.…more
$6.40-0.16%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.2After-hours26.09.03 05:30
●●●●●●●● ●●●●● ●●●●●●
Olema Oncology has granted 650,000 stock options to its newly appointed CFO as an employment inducement award. This disclosure is in accordance with Nasdaq listing rules regarding standard executive compensation packages.…more
$6.40-0.16%vs prev close - 8.31After-hours26.09.01 05:30
●●●●●●●● ●●●●● ●●●●●●
Olema Oncology announced its participation in three upcoming investor conferences scheduled for September. These events will feature fireside chats to discuss the company's clinical pipeline and progress.…more
$6.40-0.16%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report